Article ; Online: Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With
JTO clinical and research reports
2023 Volume 5, Issue 2, Page(s) 100628
Abstract: Trastuzumab deruxtecan, an antibody-drug conjugate targetingHER2-expressing tumor cells, was found to have promising results in treatment-refractory, metastatic NSCLC ... ...
Abstract | Trastuzumab deruxtecan, an antibody-drug conjugate targetingHER2-expressing tumor cells, was found to have promising results in treatment-refractory, metastatic NSCLC harboring |
---|---|
Language | English |
Publishing date | 2023-12-26 |
Publishing country | United States |
Document type | Case Reports |
ISSN | 2666-3643 |
ISSN (online) | 2666-3643 |
DOI | 10.1016/j.jtocrr.2023.100628 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.